AGENDA
Saturday, January 23, 2027
7:30 – 8:00 AM
Registration, Breakfast, and Exhibits*
8:00 – 8:45 AM
Industry-Sponsored Event*
8:45 – 9:00 AM
Break and Exhibits*
9:00 – 9:15 AM
Introduction: Conference Overview and Objectives*
SESSION A: Optimal Timing for TIPS in North American Practice
9:15 – 9:20 AM
Moderator Introduction
9:20 – 9:40 AM
State-of-the-Art Review
9:40 – 10:10 AM
Pro/Con Debate: Preemptive TIPS Is the Standard of Care
10:10 – 10:30 AM
Audience Participation, Q&A, and Voting
10:30 – 10:45 AM
Key Takeaways and Clinical Implications (Way Forward)
10:45 – 11:15 AM
Break and Exhibits*
SESSION B: Evidence-Based Symptom Management in Patients with Cirrhosis
11:15 – 11:20 AM
Moderator Introduction
11:20 – 11:40 AM
State-of-the-Art Review
11:40 AM – 12:10 PM
Pro/Con Debate: Routine Screening for Covert Hepatic Encephalopathy
12:10 – 12:30 PM
Audience Participation, Q&A, and Voting
12:30 – 12:45 PM
Key Takeaways and Clinical Implications (Way Forward)
12:45 – 1:15 PM
Lunch and Exhibits*
1:15 – 2:00 PM
Industry-Sponsored Event*
2:00 – 2:30 PM
Roundtable Discussion*
SESSION C: The Evolving Role of Albumin in the Management of Cirrhosis
2:30 – 2:35 PM
Moderator Introduction
2:35 – 2:55 PM
State-of-the-Art Review
2:55 – 3:25 PM
Pro/Con Debate: Long-Term Outpatient IV Albumin Use in Patients with Cirrhosis and Ascites
3:25 – 3:45 PM
Audience Participation, Q&A, and Voting
3:45 – 4:00 PM
Key Takeaways and Clinical Implications (Way Forward)
4:00 – 4:15 PM
Break and Exhibits*
SESSION D: The Use and Misuse of Prophylactic Antibiotics
4:15 – 4:20 PM
Moderator Introduction
4:20 – 4:40 PM
State-of-the-Art Review
4:40 – 5:10 PM
Pro/Con Debate: Secondary Prophylaxis of Spontaneous Bacterial Peritonitis
5:10 – 5:30 PM
Audience Participation, Q&A, and Voting
5:30 – 5:45 PM
Key Takeaways and Clinical Implications (Way Forward)
5:45 – 6:00 PM
Conference Summary and Closing Remarks
6:30 – 8:00 PM
Faculty and Sponsor Reception*
*Non-accredited sessions.